Cited by 61Mobile Health and mHealth ApplicationsAsthma and respiratory diseasesChronic Obstructive Pulmonary Disease (COPD) Research

Clinical effect on uncontrolled asthma using a novel digital automated self-management solution: a physician-blinded randomised controlled crossover trial

Open access
Ljungberg, Henrik, Carleborg, Anna, Gerber, Hilmar, Öfverström, Christina, Wolodarski, Jakob, Menshi, Faiza, Engdahl, Mikaela, Eduards, Marianne +1 more·2019·European Respiratory Journal

Abstract

INTRODUCTION: AsthmaTuner is a novel self-management system consisting of a patient app, a cloud-based storage solution and a healthcare interface. Patients use Bluetooth spirometers to measure lung function (forced expiratory volume in 1 s) and can register symptoms. They then receive immediate feedback on asthma control and an image of the correct inhaler(s) to use and the dose. The aim of this pilot study was to evaluate the effect of AsthmaTuner on symptom control and adherence compared with conventional treatment. MATERIAL AND METHODS: This multicentre physician-blinded crossover trial randomised patients in two groups that started with 8 weeks of AsthmaTuner or conventional treatment using a personalised printed treatment plan, with 2 weeks of washout between the crossover treatments. Participants in a primary or paediatric care setting in Sweden with asthma diagnosis, uncontrolled symptoms and Asthma Control Test (ACT) score <20 points were included. Symptom control was analysed using t-tests for the difference between the group means of the sums of ACT scores at each treatment end-visit, with 95% confidence intervals. Medical Adherence Report Scale (MARS) scores captured differences in adherence (remembering to take asthma medication) between treatment periods. RESULTS: The study population consisted of 77 patients (60% females). The ACT score significantly improved with AsthmaTuner compared with conventional treatment (mean ACT difference 0.70, 95% CI 0.06-1.34; p=0.03). Adherence did not improve significantly in all participants, but did improve among those in primary care who used AsthmaTuner an average of once a week or more compared with conventional treatment (mean MARS difference 0.45, 95% CI 0.13-0.77; p=0.01). CONCLUSIONS: AsthmaTuner improved symptom control in patients with uncontrolled asthma compared with conventional treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1183/13993003.00983-2019

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ljungberg, H., Carleborg, A., Gerber, H., Öfverström, C., Wolodarski, J., Menshi, F., Engdahl, M., Eduards, M., & Nordlund, B.
Affiliations
  • Karolinska University Hospital (SE)
  • Karolinska Institutet (SE)
  • Sophiahemmet Hospital (SE)
  • Region Stockholm (SE)
Venue
European Respiratory Journal
Published
2019-09-03
Volume
54
Issue
5
Pages
1900983
ISSN
  • 0903-1936 (ISSN-L)
  • 1399-3003
OpenAlex
W2971745569
Cited by
61
References
23
Citations by year
2026: 6 · 2025: 17 · 2024: 11 · 2023: 11 · 2022: 8 · 2021: 5 · 2020: 3
FWCI
5.45
Type
journal article
Language
en
Open access
Locations
  • European Respiratory Journal (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Bio-X, Uppsala BIO
  • VINNOVA
  • Stockholms Läns Landsting (Innovation Foundation)
  • Capio Research Foundation
  • Medituner AB
Topics
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Physiology › Asthma and respiratory diseases
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Keywords
uncontrolled asthma, asthma self-management, digital health apps, FEV1, asthma control, medication adherence, Asthma Control Test, primary care, childhood asthma
MeSH terms
Self-Management, Adolescent, Adult, Aged, Asthma, Child, Female, Humans, Male, Middle Aged, Physicians, Pilot Projects, Spirometry, Single-Blind Method, Treatment Outcome, Cross-Over Studies, Anti-Asthmatic Agents, Young Adult, Mobile Applications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review